Clik here to view.
Misonix CEO steps down | Personnel Moves October 4, 2016
Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 4, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Samsung Biologics IPO could reach $2B, company value above $8B
Biotech drug contract manufacturer Samsung BioLogics could pull in as much as $2 billion through an initial public offering, according to regulatory filings posted this week. The figures would...
View ArticleClik here to view.
New chinese FDA list of medical devices exempt from clinical trial requirements
By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: The China Food and Drug Administration (CFDA) has expanded the number of medical devices that do not require clinical trials for...
View ArticleClik here to view.
Researchers develop glucose-sensing contact lens
Researchers have developed a glucose-sensing contact lens as a noninvasive alternative to traditional glucose monitoring with blood tests. Glucose is a good target for optical sensing using...
View ArticleClik here to view.
QuiO raises $1m for smart injection device
QuiO said last week that it closed a $1.05 million seed round led by undisclosed investors to finish developing its smart injection device, prep for pilot studies and a 510(k) submission. The New...
View ArticleClik here to view.
Royal Philips debuts Volcano tech in Canada
Royal Philips (NYSE:PHG) said today that it debuted its Volcano catheter-based imaging and measurement systems for minimally invasive diagnostics and treatment of cardiovascular disease in Canada....
View ArticleClik here to view.
Stryker launches Lite Bio bone graft delivery system
Stryker (NYSE:SYK) said today it is launching the Lite Bio bone graft material delivery system device designed for spinal surgeries. The company said the device allows for the use of preferred graft...
View ArticleClik here to view.
Study is 1st to quantify ‘brain hacking’ tDCS fields
Researchers have successfully visualized the field of effect of transcranial direct current stimulation using a novel magnetic resonance imaging technique, according to a new study. Results from the...
View ArticleClik here to view.
How do you know when it’s time to hire a consultant?
By Chris Schorre, Emergo Group Has this happened to you lately? You spent countless hours online trying to research a specific topic, but still don’t have a solid understanding of how the process...
View ArticleClik here to view.
Nobel chemistry prize goes to molecular machinery
A group of European scientists won the 2016 Nobel Prize for chemistry for developing the “world’s smallest machines” that could be used for drug delivery. Jean-Pierre Sauvage, J. Fraser Stoddart and...
View ArticleClik here to view.
Vascular Solutions recalls Twin-Pass dual access caths
Vascular Solutions (NSDQ:VASC) said yesterday it initiated a nationwide recall of its Twin-Pass dual access catheters due to a potential for excess material in the catheter that could dislodge and pose...
View ArticleClik here to view.
Enable Injections lands $30m Series A for large-volume injector
Enable Injections Inc. said today that it closed a $30 million Series A round to bring its large-volume injector to market. The Cincinnati, Ohio-based company’s Enable Injector adheres to a patient’s...
View ArticleClik here to view.
How NxStage is changing the game: A conversation with founder & CEO Jeff Burbank
NxStage Medical (NSDQ:NXTM) was founded in 1999 on the premise that patients with chronic kidney disease would benefit from bringing hemodialysis out of the clinic and into their homes. Seventeen years...
View ArticleClik here to view.
St. Jude launches EnSite Precision cardiac mapping system in EU
St. Jude Medical (NYSE:STJ) said today it fully launched its EnSite Precision cardiac mapping system and associated tools in Europe, expanding from an earlier limited release. The St. Paul, Minn.-based...
View ArticleClik here to view.
Motion-directed microrobots for targeted drug delivery
Researchers have created tiny ‘microbots’ that are able to move and react in a fashion similar to bacteria, according to a report from the Max Planck Institute for Intelligent Systems. Bacteria use...
View ArticleClik here to view.
HHS: Medicare spent $1.5B on faulty cardiac devices
Medicare spent approximately $1.5 billion on defective heart devices implanted in thousands of beneficiaries, according to a report from the Department of Health and Human Services released in late...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 5, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Amedica reduces workforce by 38%
Amedica (NSDQ:AMDA) said today it laid off approximately 38% of its workforce to lower operating expenses. The Salt Lake City, Utah-based company said the layoffs were part of a plan implemented on...
View ArticleClik here to view.
Report: Drug device market to reach $1.8B by 2024
The global drug device combination market is expected to reach $17.7 billion by 2024, according to a new report from Grand View Research. The report points to minimally invasive alternatives like...
View Article